Literature DB >> 1403641

A model-based estimate of HIV infectivity via needle sharing.

E H Kaplan1, R Heimer.   

Abstract

Critical to understanding the spread of the human immunodeficiency virus via needle sharing among drug users is the infectivity, i.e., the conditional probability of infection given injection with a shared, contaminated syringe. A simple mathematical model was constructed that relates infectivity to the prevalence of infection in needles used by drug users, the mean shared injection frequency among drug users, the probability that a needle is disinfected prior to use, and the mean AIDS incubation time. Three of these parameters have been estimated using data from the New Haven, Connecticut legal needle exchange program. Using the polymerase chain reaction to test for the presence of HIV proviral DNA in a sample of returned needles, we determined that 67.5% were HIV positive. We were able to estimate shared injection rates and disinfection rates from surveys of drug users enrolled in the needle exchange and our syringe tracking system. Current estimates of the mean AIDS incubation time are available in the literature. Our model implies that the probability of infection per injection with a contaminated syringe equals 0.0067, which is slightly higher than the transmission probabilities of 1/300 to 1/200 estimated from needlestick studies, and a factor of 3 higher than estimates of the probability of HIV transmission per vaginal sex act from a infected man to an uninfected woman.

Entities:  

Mesh:

Year:  1992        PMID: 1403641

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  57 in total

1.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

2.  Ignoring 'downstream infection' in the evaluation of harm reduction interventions for injection drug users.

Authors:  H A Pollack
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  The cost-effectiveness of a modestly effective HIV vaccine in the United States.

Authors:  Elisa F Long; Douglas K Owens
Journal:  Vaccine       Date:  2011-04-19       Impact factor: 3.641

4.  Health and economic impacts of an HIV intervention in out of treatment substance abusers: evidence from a dynamic model.

Authors:  Anke Richter; Brett Loomis
Journal:  Health Care Manag Sci       Date:  2005-02

5.  A linear programming model for allocating HIV prevention funds with state agencies: a pilot study.

Authors:  Stephanie R Earnshaw; Katherine Hicks; Anke Richter; Amanda Honeycutt
Journal:  Health Care Manag Sci       Date:  2007-09

6.  Trends in HIV Infection Among Persons Who Inject Drugs: United States and Puerto Rico, 2008-2013.

Authors:  Andrew John Mitsch; H Irene Hall; Aruna Surendera Babu
Journal:  Am J Public Health       Date:  2016-09-15       Impact factor: 9.308

Review 7.  Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.

Authors:  R Heimer
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

8.  Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity.

Authors:  Jason Grebely; Gregory J Dore
Journal:  J Infect Dis       Date:  2011-01-31       Impact factor: 5.226

Review 9.  Estimating per-act HIV transmission risk: a systematic review.

Authors:  Pragna Patel; Craig B Borkowf; John T Brooks; Arielle Lasry; Amy Lansky; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

10.  Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review.

Authors:  Savanna R Reid
Journal:  Harm Reduct J       Date:  2009-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.